INVITED REVIEW
Embryonic epithelial membrane transporters

Michael Horster

Ludwig-Maximilians-Universität München, D-80336 Munich, Germany


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

Embryonic epithelial membrane transporters are organized into transporter families that are functional in several epithelial organs, namely, in kidney, lung, pancreas, intestine, and salivary gland. Family members (subtypes) are developmentally expressed in plasma membranes in temporospatial patterns that are 1) similar for one subtype within different organs, like aquaporin-1 (AQP1) in lung and kidney; 2) different between subtypes within the same organ, like the amiloride-sensitive epithelial sodium channel (ENaC) in lung; and 3) apparently matched among members of different transporter families, as alpha -ENaC with AQP1 and -4 in lung and with AQP2 in kidney. Finally, comparison of temporal expression patterns in early embryonic development of transporters from different families [e.g., cystic fibrosis transmembrane conductance regulator (CFTR), ENaC, and outer medullary potassium channel] suggests regulatory activating or inactivating interactions in defined morphogenic periods. This review focuses on embryonic patterns, at the mRNA and immunoprotein level, of the following transporter entities expressed in epithelial cell plasma membranes: ENaC; the chloride transporters CFTR, ClC-2, bumetanide-sensitive Na-K-Cl cotransporter, Cl/OH, and Cl/HCO3; the sodium glucose transporter-glucose transporter; the sodium/hydrogen exchanger; the sodium-phosphate cotransporter; the ATPases; and AQP. The purpose of this article is to relate temporal and spatial expression patterns in embryonic and in early postnatal epithelia to developmental changes in organ structure and function.

embryonic epithelia; membrane transporter; ion channel; morphogenesis


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

PHYSIOLOGICAL ANALYSIS OF embryonic epithelial membrane transporters is providing increasing data on gene messages and their specific proteins in defined embryonic cell populations. Although recent studies on the expression of membrane transporters in differentiated organs have been summarized in outstanding reviews (e.g., 26, 30, 37, 79), work of the past decade on transporters in embryonic epithelial organs and their cell types has not yet been reviewed critically. In particular, a comparative description of membrane transporter expression, in terms of temporal and spatial patterns, of the same transporter or transporter family in different embryonic epithelial organs has not been made. Organogenesis of epithelial systems, in general, is governed by basic processes that are similar in different epithelial organs, such as lung (38), kidney (40), pancreas (34, 69), and salivary gland. Among these processes are early induction of mesenchymal blastema and its transition to epithelium, branching morphogenesis of induced epithelial primordia, and actions of signal molecules, as illustrated for some of these events in renal organogenesis (Fig. 1). Because stages of morphogenesis are well defined, and morphogenic factors and mechanisms are being evaluated increasingly for different epithelial organs (e.g., 38, 40), the present article attempts to relate changes in membrane transporter expression to developmental stages. Although progress in the area of epithelial transport differentiation would appear to have been substantial since the publication of an early review1 on renal transport, most of the key processes such as the role of established transcription factors (e.g., Pax-2, WT-1, HNF-1a, SP1, and SP3) in the temporospatial expression of embryonic membrane transporter patterns remain to be understood.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 1.   Scheme of general mechanisms and regulatory factors involved in morphogenesis of the kidney. Some of these, e.g., branching morphogenesis and mesenchyme-to-epithelium transition (MET), are common to various epithelial organs, whereas most regulatory factors are organ specific. Expression of plasma membrane transporters is associated with defined periods in morphogenesis, such as MET (47). Schemes of general mechanisms in organ morphogenesis, e.g., of lung (38), have been presented elsewhere. HGF, hepatoctye growth factor; GDNF, glial cell line-derived neurotrophic factor; ECM, extracellular matrix.


    AMILORIDE-SENSITIVE EPITHELIAL SODIUM CHANNEL
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

The highly selective amiloride-sensitive epithelial sodium channel (ENaC) mediates electrogenic sodium transport and is the rate-limiting step of sodium absorption in epithelia of the distal nephron and colon, airways, and salivary ducts. Although renal, colonic, and salivary ENaC-mediated sodium absorption maintains extracellular sodium homeostasis, pulmonary sodium transport is the primary driving force for lung liquid clearance at birth. Inherited ENaC mutations are inactivating (loss of function), as in pseudohypoaldosteronism type I (PHA-1), or activating (gain of function), as in Liddle's syndrome. Targeted disruption of subunit loci in the embryo has uncovered much of their functional roles in ENaC-mediated sodium transport.

Expression of ENaC subunits (12) has been measured specifically in embryonic and perinatal epithelia of lung (1, 24, 48, 61, 67, 71, 72, 74, 75, 87, 88, 98, 99, 101) and kidney (44, 62, 49, 97, 100) in humans (61, 98, 99), guinea pigs (24), rats (44 67, 71, 74, 75, 87, 97, 99), and mice (1, 48, 49, 62, 72, 87).

In embryonic rat lung (Fig. 2), alpha -ENaC expression begins (67, 88) in the late canalicular and saccular stage [embryonic days (E)17/18-E19], concomitant with Na-ATPase (66), but not in the earlier pseudoglandular stage; it rises to the highest mRNA subunit abundance around term, with a simultaneous increase (75) of aquaporin-4 (AQP4; see Fig. 4), and it decreases from postnatal days (P)1-P7 (88). The beta - (87) and gamma -subunit expressions, by contrast, are induced postnatally (P1-P7). Similar to this divergent temporal pattern is the effect of exogenous corticosteroids (88). Dexamethasone, given to mothers between E17 and E19, increased embryonic alpha -subunit expression but not that of the beta - and gamma -subunits within 8 h after injection, much like the effect of the glucocorticoid and thyroid-stimulating hormone together (67), whereas thyroid hormone triiodothyronine (T3) alone, or combined with dexamethasone, did not increase any of the subunits (88). Because the alpha -ENaC subunit alone suffices to express part of the sodium channel activity (12), the sole rise of this subunit either in early postnatal or in embryonic lung, depending on the species (24, 61, 87), should be capable of driving initial alveolar fluid clearance. Indeed, the first report (48) on the alpha -null phenotype [alpha -ENaC (-/-)] indicated that lungs of these newborn mice, although histologically normal, showed patchy filling of the alveolar space, and the animals died within 40 h after the transition to air-breathing. By contrast, the beta -ENaC deletion (62), although associated with a lethal phenotype, did not result in the development of respiratory functional or morphological failure, suggesting that alpha - and gamma -subunits alone might generate sodium channel activity just appropriate for perinatal respiratory survival.


View larger version (77K):
[in this window]
[in a new window]
 
Fig. 2.   Expression patterns of mRNA abundance of amiloride-sensitive epithelial sodium channel (ENaC) subunits in kidney and lung. Temporal patterns of some transporters (Figs. 2-5) and their subunits are presented for rat embryonic and postnatal expression only, because 1) data in other species are less abundant and 2) comparison between species is limited by the fact that organ morphogenesis (e.g., nephrogenesis) in some species (mouse, rat) extends beyond embryonic life, whereas in others (sheep and human) it is completed before birth. Relative abundance of mRNA expression at different stages of morphogenesis, as delineated by embryonic (E) and postnatal (P) age, is represented by width of horizontal lines. Thick vertical line, transition from embryonic to postnatal epithelial cell differentiation; circles, ref. nos.

The sensitivity of pulmonary ENaC expression to oxygen content of the medium had been established earlier in cultured fetal rat lung epithelia (71), where, remarkably, the switch from 3 to 21% O2 increased the abundance of alpha -, beta -, and gamma -ENaC subunits, implying that a similar rise on P1 (75) might be induced by the change in blood O2 content after birth. Although the fetal expression change in response to O2 (from 3 to 21%) was homogeneous in all subunits (71), the unstimulated pattern (87) showed early embryonic temporal patterns that were differential for the subunits. The expression of the gamma -subunit follows the alpha -ENaC pattern, but that of beta -ENaC rises gradually from P1 to adult (87). The embryonic spatial patterns are similar for alpha - and gamma -subunits, with a prevalence of the gamma -subunit in early embryonic acinar and in small airway cells, whereas the beta -subunit localized mostly to small airway cells. Remarkably, alpha - and gamma -subunits in the adult appear to localize to the AII cell type (87). The O2-induced ENaC subunit mRNA levels (71, 74) imply the induction of O2-responsive elements (71) and, indeed, a change in intracellular superoxide expression was associated with the activation of a redox-sensitive transcription factor, nuclear factor-kappa B (74), which was blocked, as was the O2-induced increase in ENaC, by a superoxide scavenger.

Subunit temporal expression patterns were further examined (88, 101) in lung and colon and found to be differential both within the lung and particularly between these organs. Lung alpha -abundance is consistently higher than that of beta - (88) or gamma - (101), most impressively so from E19 to P2 and from P9 to P28 (Fig. 2). Remarkably, the mRNA amount of each subunit on P1 is almost as high as on P28. Thus the early expression specifically of the alpha -ENaC subunit (Fig. 2), even before the need for ENaC protein function, is to ensure neonatal fluid removal (clearance), in concert with the early expression of AQP (see Fig. 5) from epithelial surfaces. Nevertheless, pulmonary differences in temporal expression of mRNA abundance (Fig. 2) suggest divergent and independent functions of the subunits that might also imply differential subunit O2 sensitivities.

In human lung, ENaC mRNA appeared to rise continuously from fetal to adult expression level (99), but alpha -ENaC message was found only at the end of the second trimester (61), whereas all subunits were first expressed in week 21 (98). The low and differential expressions of the subunits in week 24 cultured lung (98) were increased by a factor of two to three by dexamethasone, not by thyroid (T3) hormone (88, 98), mainly at the transcriptional level. These effects on ENaC mRNA abundances suggest that promoter regions of ENaC subunits might have glucocorticoid response element sequences, but they do not imply any functional (posttranslational) consequences.

Renal ENaC expression patterns (Fig. 2), by contrast, although established early in nephrogenesis mostly by principal cells (44), are increasingly responsible for postnatal sodium homeostasis; it is relevant in this context that the temporospatial pattern of nephron differentiation from deep to superficial cortex (40) puts the renal workload at birth, in several species, on the almost mature nephron generations in the deep cortex. In humans, however, nephrogenesis is completed at about weeks 34-35 of gestation. Total renal embryonic rat ENaC subunit mRNA abundance is very low but increasing from E16 to E19 (97), and it rises abruptly from E19 to E22 to almost adult levels of expression at P1-3 in all subunits (Fig. 2), indicating that the distal nephron does not have the divergent embryonic subunit mRNA expression pattern that characterizes pulmonary ENaC development.

A detailed study of alpha -ENaC in the ureteric bud (UB) revealed that, surprisingly, this subunit and the sodium channel protein are expressed and functional (44) in rat UB (and embryonic collecting tubule) well before filtrate delivery, suggesting that the other subunits (100) also might be functional in this progenitor cell of the cortical collecting duct (CCD) cell populations. Moreover, the acquisition of apicobasal cell polarity, a hallmark of nephrogenesis (39) after mesenchyme-to-epithelium transition (45), also pertains to the sided expression of the ENaC functional protein (41, 44). The early expression (E17) was confirmed because each of the subunit antisense riboprobes hybridized to collecting ducts, whereas only beta - and gamma -subunits were detected in the most distal uroepithelia (100). Although whole kidney alpha -ENac mRNA abundance increased, and beta - and gamma -subunit abundance decreased after birth, there was a striking shift of the collecting duct expression pattern from inner medullary to cortical localization (100).

The functional roles of the ENaC subunits in epithelial sodium transport were studied in several mouse organ systems and subunit-knockout models (1, 48, 49, 72). As mentioned for the alpha -ENaC (-/-) phenotype, failure of pulmonary fluid clearance was the primary cause of early postnatal death although alpha -ENaC transcripts could not be detected in both lung and kidney (48). In subsequent work, the alpha -ENaC (-/-) with transgenic expression of alpha -ENaC resulted in a partial restoration of alpha -mediated sodium reabsorption specifically in lung, and liquid clearance was sufficient for the newborn to survive the early postnatal period; however, renal manifestations of reduced alpha -ENaC expression were salt wasting and metabolic acidosis with elevated aldosterone, thus resembling a compensated PHA-1 syndrome. When the beta -subunit gene was disrupted (72), the mutant newborn mice (beta -ENaC m/m) still were able to clear their lung liquid despite a sixfold reduction in ENaC-mediated tracheal transport, but compensated metabolic acidosis and elevated aldosterone levels indicated a compensated PHA-1 phenotype on a normal-salt diet. On low-salt intake, however, the reduced beta -ENaC mutants revealed the PHA-1 phenotype with renal and colonic expression, such as elevated serum potassium (6 mM), lower blood pressure, and elevated aldosterone (72). Of interest, beta -ENaC (-/-) mice, which are hyponatremic and hyperkalemic with corresponding urinary excretion patterns and elevated aldosterone, display the collecting duct dysfunction phenotype of human PHA-1 without defects in pulmonary or renal morphology (62). Last, the gamma -ENaC (-/-) resulted in a lethal PHA-1 phenotype (1), which, however, did not lead to respiratory failure during the first 24 h postnatally but to severe hyperkalemia of probably renal origin that appeared to be the leading cause of death in the gamma -mutants (1). Colonic ENaC expression patterns were qualitatively similar for all subunits, the increase in their mRNA abundance being gradual, with alpha -subunit mRNA having the highest value throughout (101).

In conclusion, expression patterns of ENaC subunits in kidney, lung (Fig. 2), and colon differ fundamentally, and regulatory mechanisms, e.g., O2 and steroid hormones, appear to act in organ-specific ways in embryonic and postnatal differentiation.


    INWARDLY RECTIFYING K+ CHANNELS
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

Inwardly rectifying K+ (Kir) channels constitute diverse subfamilies, such as ATP-sensitive and ATP-dependent potassium channels, and they participate, among many diverse functions, in maintaining potassium homeostasis and resting conductance. For the Kir family, as for ENaC, distinct temporal expression patterns have been described, specifically for some Kir members in embryonic (Braun GS, Huber SM, Veh RW, Segerer S, and Horster MF, unpublished observations) and in postnatal (Braun GS, Huber SM, Veh RW, Segerer S, and Horster MF, unpublished observations; 77, 111) renal epithelial development. Thus ROMK, Kir6.1, and its associated sulfonylurea receptor SUR2, were found to be expressed in a development-dependent mode (Braun GS, Huber SM, Veh RW, Segerer S, and Horster MF, unpublished observations) in defined stages of collecting duct morphogenesis, in mesenchyme-to-epithelium transition, and in nephron formation, where they might serve specific developmental functions. It is of particular interest that Kir6.1 (protein) is faintly expressed in mesenchymal blastema, upregulated at the mRNA and protein level in condensed mesenchyme, and downregulated in the S-shaped body (47). In collecting duct ontogeny, Kir6.1 and SUR2 mRNAs are downregulated with time, whereas ROMK2 mRNA is upregulated by cAMP, suggesting that vasopressin might function as transcriptional regulator in development (Braun GS, Huber SM, Veh RW, Segerer S, and Horster MF, unpublished observations). The ROMK isoforms, when analyzed by immunofluorescence, are selectively expressed in the apical plasma membrane of mature thick ascending limb of Henle and of CCD principal cells (30, 37). By contrast, ROMK is not expressed in the nephrogenic zone or in midcortical CCD of postnatal week 1 rat kidney, whereas midcortical CCDs (week 3) were clearly stained (111). This postnatal change in ROMK protein abundance may be responsible for the increase in the number of open potassium channels, i.e., the number of functional channel proteins reported earlier in postnatal rabbit principal cells (77).

It may be concluded that embryonic ROMK, Kir6.1, and SUR2 expressions are involved in developmental processes such as cell cycle, mitosis, and mesenchyme conversion rather than in potassium homeostasis and that these latter functions are gradually acquired for the mature nephron (30).


    CHLORIDE TRANSPORTERS
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

Chloride (anion) transporters (channels) not only have a leading role in cell volume regulation, but they also participate in stabilizing potassium-mediated membrane potential and in acidifying intracellular compartments. Chloride transporter genes from distinct families that are developmentally expressed include the cystic fibrosis transmembrane conductance regulator (CFTR) (22, 34, 41, 59, 60, 63, 86, 90, 91, 110), ClC-2 (42, 43, 65), ICln (42, 102), the bumetanide-sensitive Na-K-Cl symporter (NKCC2) (51, 78, 89, 96), the Cl/HCO3 antiporter (58), and the Cl/OH antiporter (80).

CFTR

The cAMP-activated chloride channel, a member of the ABC transporter superfamily, functions as a regulator of other channels and may be more important in regulating embryonic channel expressions, cationic and anionic, than has been appreciated thus far. Expression of the CFTR has been measured in embryonic and postnatal lung (34, 59, 60, 63, 86, 90, 91), kidney (22, 41), and pancreas (34, 90) in humans (22, 34, 59, 60, 90, 91), rabbits (63), and rats (41, 86). Although up- or downregulation of some transporters coincides with the transition from embryonic to postnatal life (Fig. 2 and see Fig. 4), CFTR and ClC-2 apparently have a more complex expression pattern. In human lung, CFTR mRNA is found in the first trimester, and mRNA and protein in the second, i.e., very early in gestation (59). In cystic fibrosis lung, CFTR expression (34) but no cAMP-stimulated fluid secretion was reported for explants (59). Despite this secretory conductive defect, lung morphology was normal, suggesting additional embryonic mechanisms of chloride and fluid secretion compensating for the defective CFTR secretory pathway, as postulated also for the CFTR-deficient mouse, which has normal embryonic lung morphogenesis (110). The supposed CFTR-independent chloride transport is upregulated by keratinocyte growth factor, which, probably due to osmotic fluid accumulation, causes cystic dilation and disrupted branching morphogenesis of lung buds (110). Analysis of the human embryonic temporospatial pattern of CFTR by in situ hybridization (60, 91) revealed a bronchial centrifugal expression gradient (60), diminishing from bronchi to bronchioles and to prealveolar tubes, specifically in AII cells and their precursors, whereas the mesenchyme did not express the channel message. When CFTR mRNA signals were evaluated throughout development (91), from human embryonic week 10 to postnatal year 2, a more differentiated pattern emerged, namely, high expression levels in all distal epithelia and small airways in the first trimester, relatively reduced proximal expression in second, and high expression in small distal airways, but reduced in the future alveolar space, in the third trimester; neonatal lung had no alveolar or tracheal expression (91). Expression levels of CFTR mRNA, in general, are lower in respiratory epithelia at all embryonic stages compared with those of the gastrointestinal tract, where expression of CFTR was specific to progenitor cells of intestinal crypts (90), in particular on apical surfaces (65). The polar membrane distribution of CFTR (63), as for other membrane channel types and transporters (40), is acquired with cell differentiation; specifically, the protein in E22 (rabbit) is distributed in a nonpolar way, and it becomes localized exclusively to the apical membrane on E29 (63). Like other embryonic transporters (106), CFTR functional activity, without correspondingly large changes in CFTR mRNA, is modulated in embryonic lung (rat) by steroid hormones (86), suggesting translational or posttranscriptional regulation of CFTR in embryonic distal lung epithelia. Similarly, CFTR functional activity decreased progressively during late- gestation morphogenesis, from the pseudoglandular to the saccular stage (86), but CFTR mRNA abundance remained unchanged.

In embryonic kidney (Fig. 3), by contrast, CFTR mRNA abundance in UB cells declined between gestational E15 and postnatal P1, rising transiently by a factor of 10 between P1 and P7 (41), a period corresponding to the late stage of rat kidney branching morphogenesis (40), and was downregulated thereafter.


View larger version (99K):
[in this window]
[in a new window]
 
Fig. 3.   Expression patterns of cystic fibrosis transmembrane conductance regulator (CFTR), ClC2, and ICln mRNA in kidney. Epithelial cell functional differentiation was followed from ureteric bud (E15) to cortical collecting duct (P14) during branching morphogenesis. Relative abundance of mRNA expression is represented by width of lines; circles, ref. nos.

Of interest in this context is the finding (41) that wild-type and truncated forms of CFTR mRNA have different patterns of developmental regulation in UB. The human renal CFTR expression pattern (22) is characterized by early appearance (weeks 12-19) of the multifunctional (79) CFTR protein in the apical plasma membrane of UB, but not in comma- or S-shaped body, a pattern similar to that in pancreas (34) and lung during branching morphogenesis.

To summarize, the early expression of CFTR, its transient decrease in the last gestational (rat) trimester (Fig. 3), its bronchial centrifugal expression gradient, and the shift from apolar to apical localization might suggest CFTR regulatory functional roles not only for other chloride channels (e.g., ClC-2, ICln) but also for ENaC, which is upregulated concomitantly (44).

ClC-2

This member of the large ClC family is expressed ubiquitously, and embryonic renal and pulmonary mRNA temporal expression patterns are quite similar. Renal ClC-2 mRNA is most abundant in E19 (rat), and it is downregulated in kidney, lung, and intestine perinatally (65), suggesting developmental housekeeping functions that become less important in postnatal life. Embryonic ClC-2 expression is highest in kidney and least in lung, indicating that lung fluid secretion is driven by many chloride conductances, which are either cAMP dependent or independent. Although ClC-2 and CFTR are coexpressed in embryonic intestine, along apical surfaces of villi and crypts (65), their spatiotemporal expression patterns in embryonic lung and kidney are different (41, 42, 65), in contrast to the patterns for ClC-2, which are similar in both arborizing organs (42). Because early pulmonary bronchi and renal CCD have branching morphogenesis in common, the temporal pattern of ClC-2 mRNA expression was analyzed in UB and collecting duct epithelia (42). In embryonic UB cells (Fig. 3), mRNA encoding the ubiquitous volume-regulatory ClC-2 is highly abundant, and it is downregulated in the postnatal collecting duct (42). This pattern corresponds to that in lung, where embryonic chloride and fluid secretion into the lumina appear to have morphogenetic functions. In fact, the renal embryonic precursor cell type of the CCD principal cell, the UB cell at the tip of the branching ureter, expresses embryonic ClC-2 mRNA at the single-cell level (43). The lumen of the ampullary part of the UB may thus be maintained by ClC-2-mediated chloride and by AQP2-mediated fluid secretion.

In lung, ClC-2 mRNA is expressed in an almost identical temporal pattern, and downregulation of ClC-2 apparently is associated with the switch of embryonic respiratory epithelia from fluid secretion to reabsorption at birth, when alpha -ENaC (88) and AQP1 (94, 107) are upregulated.

To conclude, the changing functional role (79) of the CFTR mRNA pattern in nephrogenesis, as mentioned, might be that of a molecular switch downregulating ClC-2-mediated chloride (and fluid) secretion and upregulating ENaC-mediated sodium (and fluid) absorption on initiation of glomerular filtration. The inversely related mRNA abundances of these transporters in different embryonic and perinatal stages appear to support this hypothesis.

Expression of ICln (Fig. 3), a further swelling-activated, volume-regulatory channel or channel regulator (102), was compared with that of ClC-2 during renal branching morphogenesis (42). Although ClC-2 mRNA abundance increased from E15 to E17, peaked around P3, and decreased from P3 to P7 (Fig. 3), similar to the temporal pattern in lung (65), mRNA expression of ICln increased during the entire embryonic and postnatal period of development (42), extending data in mouse kidney where a single transcript was found to be expressed at similar levels in embryonic stages between E7 and E17 (102). The pattern of ICln mRNA abundance, to summarize, follows that of increasing vectorial solute transport after P7 with its, by now, enhanced requirement for volume regulation (47), whereas the ClC-2 temporal expression pattern suggests specific embryonic functions in epithelia undergoing branching morphogenesis.

Embryonic epithelial cell volume regulation and its developmental course have been evaluated in UB cells and CCD cells in culture, and it was shown that the mature type of hypotonic swelling-activated chloride conductance may evolve already between E17 and P1 (47). Embryonic UB cells had a high and constitutively active chloride conductance, whereas perinatal and postnatal cells, by contrast, expressed a chloride conductance that was activated by hypotonic cell swelling (47), and the embryonic conductance type was downregulated simultaneously.

The chloride transporter NKCC2 is highly and early (E16.5, mouse) expressed in the metanephric kidney (51), and three isoforms have been identified in embryonic human kidney (96), where loss-of-function mutations can cause the antenatal (inherited) hypokalemic alkalosis of Bartter's syndrome (85). The first embryonic expression (E14.5, mouse) is localized to the distal limb of the immature loop of Henle, in cells close to future glomeruli, before the morphological differentiation of the loop into thin and thick ascending segments (51). These data were confirmed and extended to the postnatal nephrogenic (P3/P4, rat) zone and to deeper cortical areas (78). NKCC2, as in embryonic mouse, is first expressed in macula densa cells of the thick ascending limb, and it appears earlier than the sodium-phosphate cotransporter (NaPi) in the pars recta (78). These and other transporters are expressed embryologically even before completion of organ structure (e.g., of the post-S-shaped stages in the nephrogenic zone) and the onset of filtration or of ventilation, such as in embryonic (sheep) lung epithelia in culture, where NKCC2 may drive the chloride secretory pathway (89), suggesting that these molecules might have a morphoregulatory role. This function is by now also ascribed to polycystin, an integral membrane protein and polycystic kidney disease 1 (PKD-1) gene product, in human (29, 50) and in mouse (28, 31, 95) embryonic kidney, lung, salivary gland, and pancreas, where polycystin is highly expressed throughout major stages of organogenesis, such as mesenchymal condensation and tissue patterning. In the kidney, polycystin expression is very high in differentiating and very low in differentiated UB and CCD mouse epithelia, respectively (29). Transcript levels were detected in UB branches on E12 (31), peaked from E16 to E19, and were abruptly downregulated to very low adult levels in week 1/2. Indeed, the PKD-1 gene product polycystin was shown to regulate branching morphogenesis of mouse UB (95), and its mode of function may resemble that of a channel/receptor subunit. In human kidney, the PKD-1 protein is expressed in collecting duct and distal convoluted tubule on week 20 (50), and at a high level even earlier (week 14) in UB/CCD apical membrane but not in mesenchyme (29), with a general decrease after week 18 in kidney and pancreatic duct to undetectable levels in adult (29).

The chloride/anion antiporters, Cl/OH in proximal straight tubule (80) and Cl/HCO3 in mesonephric collecting tubule (58), have distinct developmental expression patterns. In mesonephric kidney, which in rabbit is functional from E13 to E19 (in sheep from E15 to E55, and in humans from week 5 to week 16), the collecting duct expresses (in ~1/3 of the CD cells) the intercalated A-type cell of the later metanephric kidney, as indicated by apical H-ATPase and basolateral Cl/HCO3 immunoexpression (58), suggesting that lineages of the metanephric collecting duct cell populations are already expressed in the mesonephros. In proximal straight tubule (rabbit), the functional activity of the Cl/OH antiporter was about sevenfold less in neonatal compared with adult S2 segments (80) and notably similar to the rate change in the Na/H antiporter (NHE3), indicating that developmental changes in proximal tubule NaCl transport are mediated by similar changes of these cooperating transporters (80). The heterogeneous families of chloride transporters, to summarize, appear to serve various undefined embryonic and postnatal functions, as suggested by the distinct temporal patterns of up- and downregulation in different morphogenic periods.


    SODIUM-GLUCOSE SYMPORTER-GLUCOSE UNIPORTER
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

Transcellular vectorial movement of glucose in epithelial cells, i.e., uptake and release, results from concerted actions of members of two families of regulated glucose transporters, the isoforms of sodium-glucose symporter (SGLT) in the apical and of glucose uniporter (GLUT) in the lateral plasma membrane. Their embryonic expression is tissue specific and regulated developmentally.

SGLT and GLUT have been evaluated in embryonic and postnatal stages of intestine (9, 14, 20, 56, 57, 73, 82, 92), kidney (4, 108), lung (35, 84), and pancreas (36, 69) in humans (20, 56), pigs (73), cats (9), rabbits (4), and rats (14, 35, 36, 57, 69, 82, 84, 92, 108).

SGLT-1, the high-affinity symporter in human intestine, is expressed first in week 17 of gestation (20), and it increases from a low embryonic expression (57) with development. Apical glucose (SGLT-1) and D-fructose uptake (rat), when studied from P1 to P42 (92), had a steep rate increase after P21 to adult, and it declined thereafter. Interestingly, the ratio of intestinal glucose uptake to that for galactose and for fructose changes with postembryonic ontogeny (73). Although the galactose-to-glucose and fructose-to-glucose transport ratios have a similar course between birth and P10, galactose-to-glucose ratio decreases sharply after P10, and that of fructose to glucose, as might be anticipated, increases further (73). Monosaccharide transporters, in general, are already acquired embryonically before substrate delivery to these transporters (73), similar to ENaC expression in kidney and lung before the onset of filtration and ventilation, respectively.

SGLT-2-mediated glucose transport in late embryonic renal brush-border membranes has the same affinity but a reduced maximal velocity (Vmax) compared with that in adults, suggesting that the increase in SGLT-2 expression (4) may also represent an adaptive intestinal change of transporter availability in response to the gradual postnatal shift in diet (9). This latter factor appears to be relevant for the biphasic expression pattern of the ileal sodium-dependent bile acid (taurocholate) transporter ASBT mRNA (81). Both mRNA and protein abundance are high on E22, downregulated in P1-P7 relative to E22, and markedly increased at weaning (P21, rat). This pattern is similar to rBAT mRNA expression, a cystine-related absorption system in embryonic renal pars recta (25).

Expression patterns of organic ion transporters related to the organic cation transport family (OCT) were examined recently in murine development (69a). Although NKT/mOAT (55), Roct, OCT-1, and NLT transcript levels increase during embryonic development almost pari passu in proximal tubule, their mRNA expression in extrarenal sites decreases impressively, thus raising the possibility that OCTs might have a role in morphogenesis.

Renal SGLT-1 mRNA is expressed on E18 (rat), and it increases up to P1 (108). By contrast, SGLT-2 expression began on E17, rose up to E19, and declined between E19 and P1 when, notably, the size of the message changed from an embryonic (2.6-kb) to the postnatal (2.2-kb) form, suggesting developmental splice variants of the low-affinity symporter similar to the CFTR embryonic variant (41).

GLUT-5 in human small intestine is immunoexpressed as early as gestational week 15 in the apical membrane (56), whereas GLUT-2 mRNA has been detected already in week 11 (20). This differential temporal pattern of GLUT expression pertained to all isoforms; i.e., GLUT-5 in embryonic intestine was expressed at lower abundance than GLUT-2 and both increase from low embryonic expression with development (57), whereas GLUT-1 has an early and high embryonic expression (20) and decreases postnatally, as is true for pulmonary (35) GLUT-1. Immunoreactive localization in embryonic period E10-E20 confirmed that the GLUT-1 (high-affinity) transport protein is expressed earlier than -2 and -5, and it disappears in the newborn enterocyte, whereas the others are increasingly expressed. The progressive increase in GLUT-5 transcript level was correlated with the fructose uptake pattern (14, 73); i.e., GLUT-5 mRNA expression in P22 is upregulated by luminal fructose after completion of weaning, and dietary fructose levels induce GLUT-5 mRNA abundance specifically and instantaneously (82).

Pulmonary GLUT-1 mRNA, protein, and glucose uptake in embryonic AII cells (E20, rat) are upregulated during culture in glucose-free medium and decreased in high-glucose medium (84). Mechanisms regulating transcriptional rates in response to the transported substrate for GLUT-1 and -5 (82) are unknown. In embryonic lung, in addition, the estradiol-induced magnitude of change in GLUT-1 mRNA was similar to that of protein and of glucose uptake rate, suggesting a steroid-induced increase in membrane transporter density (35).

Pancreatic immunohistochemical GLUT-2 is absent in E20 beta -cells (36), and it is faintly expressed in P1, suggesting that glucose-induced insulin secretion is developmentally reduced at the transporter level. However, in E11 pancreas, GLUT-2 protein is expressed in endoderm before bud morphogenesis, but the protein- and insulin-positive cells in acini and in duct epithelia are lost by E19, indicating embryonic and postnatal lineages of insulin expression (69).

SGLT and GLUT, to conclude, apparently have distinct isoform expression patterns, which might be similar, however, in different organs for a given isoform, as in GLUT-1, and dependent on substrate load, as in GLUT-5.


    NHE
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

The renal proximal convoluted tubule (PCT) has a central role in acid-base homeostasis, and its major part of proton secretion is carried by NHE via the low intracellular sodium concentration established by the Na-K-ATPase. The NHE isoforms (1-4) are expressed developmentally.

Embryonic and early postnatal NHE expression has been evaluated by transport activity, by mRNA and protein abundance, or by immunolocalization, in kidney of sheep (33), rabbit (2, 5), rat (3, 6, 17, 109), and in rat jejunum (16, 17).

PCT embryonic apical membrane abundance of Na/H (NHE3) protein and of amiloride-insensitive sodium uptake into brush-border vesicles (E29-30, rabbit) is much lower compared with adult (5). Although Vmax of the embryonic transporter was about threefold lower than in the adult, suggesting an increase in the number of functional transporters or in the turnover number of individual transporters, the Michaelis-Menten coefficient value (Km) was similar throughout ontogeny. Previous work had reported transport rates, Vmax, Km, and amiloride sensitivity of NHE3 to be higher at P7 than at P21 or the adult stage (109), indicating an increased capacity for antiport at the early stage. As might be anticipated, maternal glucocorticoid application (5) induced Vmax of the embryonic NHE3 antiport activity to rise precociously to an adult level, which might have been due to an increase in transcriptional efficiency. NHE3, when immunolocalized on P1, was not detected in vesicle or in early S-shaped body of the nephrogenic zone, and it was first expressed in the apical plasma membrane of the fully formed S-shaped body (6), whereas medullary thin and thick loops of Henle expressed the adult staining pattern already at this P1 stage. NHE3 mRNA abundance (rabbit) increased from very low on E30 and P1, only slightly in week 1, and sharply in week 3 to an adult level (2). In subsequent stages (rat: weeks 2, 3, 6, and adult), the pH-dependent renal sodium uptake (17) was higher in weeks 2-6 than in adult, and the abundance of NHE1 and NHE4 mRNA decreased similarly. By contrast, intestinal uptake increased slightly from week 2 to week 6 but steeply from there to adult, whereas intestinal NHE1 message remained constant (17). NHE3 expression is probably regulated at several levels, because the relative contribution of NHE3 and NHE2 to total transport activity changed with ontogeny. In early stages (weeks 2 and 3), NHE2 and NHE3 carried 40 and 60% of transport activity, respectively, whereas later (week 6) the contribution of NHE3 had increased to some 90% (16). Intestinal NHE3 mRNA and protein abundance were increased by corticosteroids on P18 about twofold (16).

Besides corticosteroids (5), thyroid hormones regulate ontogenic transcriptional activities, and these were studied in P17-20 (rat) with respect to NHE3 antiporter activity, mRNA, and protein abundance (3). Hypothyroid renal cortical NHE3 mRNA abundance was similar to that of euthyroids, but transporter activity and apical membrane protein abundance were lower. In hyperthyroids, by contrast, mRNA, protein, and transporter activity were all higher than in euthyroids (3), suggesting a regulatory role for thyroid hormones in PCT functional differentiation.

The glucocorticoid-induced embryonic expression (sheep) of NHE3 activity in PCT is similar to that during natural embryonic-postnatal transition (33); i.e., Vmax increases and Km is constant, suggesting an increase in transporter numbers under the regulatory control of corticosteroids. Remarkably, total renal sodium reabsorption was unchanged, which emphasizes the differential effects of the glucocorticoid on transport expression. NHE1 and NHE4 mRNA abundance (rat) in cortical basolateral plasma membranes decreased with postnatal ontogeny from week 2 to adult, concomitant with pH-dependent sodium uptake into basolateral vesicles (17), whereas NHE1 mRNA abundance (rabbit) was expressed at adult level already on P1 and did not change further (2) and protein profiles of both NHE3 and NHE1 were similar to those of their mRNAs. Glucocorticoid treatment in week 1 (rabbit) increased NHE3 mRNA (~2-fold) and protein (~3-fold) abundance but not that of the high-NHE1 expression level (2). To summarize, it appears that not only the contributions of NHE isoforms to pH and sodium homeostasis change with embryonic and, specifically, postnatal ontogeny but also their response to steroid-induced expression.


    NAPI
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

A systematic evaluation of the intracortical developmental (rat: P1, P13, P22, adult) profile of NaPi expression, by immunolocalization and in situ hybridization, revealed that NaPi protein and mRNA are expressed, as expected, only in those PCT of inner cortex, specifically in juxtamedullary PCT, that had acquired a brush border (93). Surprisingly, however, NaPi-2 was not expressed in any of the nephrogenic structures, i.e., vesicle, comma- and S-shaped body, and it appeared rather homogeneously throughout the cortex only on P13, i.e., when nephrogenesis (rat) is almost completed (40). The adult pattern (week 6) was reached after abundance in superficial PCT appeared downregulated compared with juxtamedullary PCT (93). NaPi transport on P21 in renal brush-border membrane vesicles of hypothyroid rat (23) was specifically and acutely restored by T3, in both Km and Vmax, and T3 also increased the abundance of NaPi-2 mRNA to control values, independently of corticosteroid effects (23).


    ATPASES
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

Na-K-ATPase is the key transporter in cellular solute and water homeostasis. With the increasing demand for transcellular solute and fluid movement in epithelia after the embryonic period of development, expression of transporters such as ENaC (88, 101), SGLT (57), and NHE (5) is upregulated and may contribute to the ubiquitous rise in the abundance of Na-K-ATPase.

Na-K-ATPase expression in embryonic lung (15, 19, 52, 66, 88) and kidney (10, 32, 70, 103) has been measured in mice (19), rats (52, 66, 103), guinea pigs (32), rabbits (15), sheep (70), and humans (10), whereas expressions of renal and gastric H-K-ATPase were studied postnatally in rabbit (18) and mouse (64), respectively.

Embryonic distal lung cells are to become air space epithelia, and their high Na-K-ATPase activity serves sodium absorption and thus fluid clearance after birth, whereas much of the ATPase abundance in embryonic airway (bronchiolar) cells is part of the chloride-secretory and thus fluid-secretory process that is required in early lung morphogenesis. In lung, epithelial cell Na-K-ATPase undergoes two major changes, i.e., in turnover rate and in the amount of enzyme in plasma membranes (15). At term (E30-P1), a fourfold increase in the ouabain-sensitive Rb uptake indicates a major change in the antiporter turnover rate, whereas postnatal development is characterized by a threefold increase of binding sites per cell, i.e., in the number of antiporters without an apparent change in the turnover rate (15). The embryonic Na-K-ATPase alpha 1- and beta 1- subunit mRNAs (66) were found in cultured distal epithelia to be faintly expressed on E17, increased on E20, and declined on E20-21. Remarkably, however, the two subunits appeared to be regulated differentially because the E17 mRNA steady-state level was higher for the alpha 1-subunit, but the increase in late canalicular/early saccular stage (E20) was higher for beta 1 than for alpha 1 (66). Also, the major rise in Na-K-ATPase mRNA was at the transition from canalicular to saccular stage, whereas the enzyme activity increased at the saccular stage.

Pulmonary embryonic mRNA abundance profiles of these two isoforms of the enzyme increased coordinately from mouse E14.5 (where they are similar to adult values) to the highest levels (6- to 8-fold higher than adult) at P1, representing the terminal saccular stage (19), and mRNA abundance of both isoforms decreased from P3 to reach final adult values at P13. The spatial pattern, by in situ hybridization, is characterized by intense alpha 1-isoform signals in proximal bronchial epithelia on P1, whereas beta 1 is expressed increasingly from E14.5 to P1 in both proximal and distal epithelia (19). It is of interest that maternal glucocorticoid treatment (52) changes the steady-state levels of the isoforms differentially. When dexamethasone was applied specifically from E14 to E16, both beta 1-subunit mRNA and protein increased on P17, but mRNA and protein of the alpha 1-subunit remained unchanged (52).

Renal embryonic Na-K-ATPase activity rose in sheep (E132) after cortisol (48 h) to levels of P1 activity; this change, however, was much higher than that of mRNA and protein (70), suggesting that most of this short-term effect was posttranscriptional, i.e., not consequent to de novo synthesis of the alpha 1-subunit, and thus similar to the effect in embryonic guinea pig kidney (32) and rat lung (88). By contrast, cortisol effects on the renal Na/H antiporter in embryonic sheep (E132) appear to be preferentially transcriptional (33). The unstimulated temporal pattern of Na-K-ATPase activity in rat juxtamedullary PCT shows an almost twofold increase from E21 to P1 (103) but much less enzyme activity in the induced mesenchyme. Detailed analysis of PCT enzyme activity (32) during embryonic-neonatal transition (guinea pig) revealed an intricate pattern, i.e., a constant Km and a large increase in Vmax and alpha - (by a factor of 7) and beta -subunit (by a factor of 4) protein abundance but only a small increase (by factor of 1.5-2) in subunit mRNA abundance, indicating either posttranscriptional upregulation of Na-K-ATPase protein synthesis or lower degradation (32).

In the metanephros of humans (10), as well as in those of other species (39), the acquisition of basolateral membrane sidedness of the enzyme is developmentally regulated because both apical and basolateral localization of the alpha -subunit is seen throughout a major part of gestation, and final polarization may be organized at the level of the beta 2-isoform expression involving the sorting pathway of the Na-K-ATPase. This important conclusion is based on the fact that beta 2-subunit mRNA and protein, but not beta 1-subunit protein, are expressed apically in distal nephron and collecting duct segments during early and midgestational metanephrogenesis. Postnatally, beta 2-subunit mRNA and protein are downregulated whereas the beta 1-subunit protein, by contrast, was upregulated (10).

H-K-ATPase protein in CCD intercalated cells is expressed early (weeks 1-2, rabbit) in apical plasma membrane (18), and thus ensures, together with the V-ATPase (18), acid excretion in the transitional period. Closer examination of the (mouse) gastric H-K-ATPase expression by membrane immunoassay revealed apparently similar control mechanisms for subunit expression, i.e., very low levels for both the alpha - and beta -subunit protein from P1 to P15, with a sharp rise to adult level on P30, and the increase was mainly due to increased subunit mRNA levels (64). It appears justified to conclude that recent work has emphasized differential developmental roles of the Na-K-ATPase alpha - and beta -subunits at the mRNA and protein level, in both the process of sided expression and the enzyme's upregulation under the control of steroids.


    AQP
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

AQPs are a family of highly conserved transmembrane channel proteins generally responsible for rapid osmotic water movements, and some nine members of this transporter family have been cloned in mammals to date. Their distribution patterns are organ and cell type specific, and their pulmonary and renal temporal developmental patterns differ fundamentally.

Expression of the aquaporins AQP1-4 in renal epithelia (7, 11, 21, 27 , 68, 76, 83, 104, 105, 106) and of AQP1, 4, and 5 in lung epithelia (13, 53, 54, 75, 94, 107) is acquired with embryonic and/or perinatal development in humans (21), sheep (11, 104), rabbits (13), rats (7, 53, 54, 75, 76, 83, 94, 105-107), and mice (27).

Temporospatial patterns are expressed differentially for each of the aquaporins in both kidney and lung (Fig. 4). In the kidney (rat), AQP1-4 are hardly detectable on E16 by immunohistochemistry (105). AQP1 mRNA rises sharply to a near-adult level in week 1 whereas AQP2 is expressed already on E18 and increases steadily up to week 4. This early AQP2 transcript appearance is accompanied by vasopressin receptor V2R mRNA expression (in situ hybridization) already at E16 in embryonic collecting duct (68). At the protein level, the earliest expression (E18) of AQP2 is in UB apical membrane, whereas basolateral AQP3 is barely detected at this stage and highly expressed on P1 (105). Except for this embryonic divergence, basolateral AQP3 and apical AQP2 patterns appear to be similar. It is relevant in the context of CCD cell lineage expression that on P1 all of the cells were AQP2 positive, whereas on P11 principal cells (by exclusive AQP2 expression) and intercalated cells (by V-ATPase expression) were clearly distinct (76). Incidentally, some CCD cells on P11 expressed both AQP2 and V-ATPase in the apical plasma membrane, suggesting developmental transitional states between these cell types. AQP4 mRNA has a faint embryonic expression (Fig. 4), and it is continuously expressed after birth in kidney and lung up to P40 (75, 105).


View larger version (78K):
[in this window]
[in a new window]
 
Fig. 4.   Expression patterns of mRNA abundance of aquaporin (AQP) subunits in kidney and lung. Relative abundance of mRNA expression at different stages of morphogenesis, E and P, is represented by width of horizontal lines; thick vertical line, transition from E to P epithelial cell differentiation; circles, ref. nos.

Because epithelial nephrogenesis (39) in many species, including rat, extends from embryonic into early postnatal life (P1-14), expression patterns of several epithelial membrane transporters also change during this later developmental phase (40). The increasing expression of AQP2 at the mRNA and protein level between P10 and P40 is paralleled by a similar rise in urine osmolality (27, 106). AQP2 mRNA abundance rose almost twofold from P10 to P20 (Fig. 4), and its protein in the principal cell apical plasma membrane stained faintly from P2 to P6, but strongly from P6 to P40 (106).

Remarkably, an adequate challenge to the signal cascade (e.g., dehydration or arginine vasopressin) when applied in the early (P1) postnatal phase (7) increases both AQP2 expression and, to a higher extent, protein insertion from the intracellular pool into the apical membrane of CCD, specifically of the glycosylated form, whereas urine osmolality remained at the nonactivated level. These latter data imply that factors in addition to AQP2 availability, V2R mRNA expression (68), and cAMP-mediated signal system capacity, as measured by developmental responses of osmotic water permeability in inner medullary collecting duct (83), contribute to the ontogeny of countercurrent function. AQP2, at any rate, is not a major limiting factor of early postnatal urinary osmotic concentration. Of particular interest, the pattern of glycosylation of the AQP2 protein switched from a preferentially nonglycosylated early form to the expression of both glycosylated and nonglycosylated forms of AQP2 in week 2 (7). When its expression was induced by glucocorticoid on P10 (106), AQP2 mRNA abundance rose by a factor of two and protein stain by a factor of eight, but there was no effect on AQP2 in adult kidney.

In human kidney, AQP1 and AQP2 are expressed as early as gestational week 12, when they appear, as shown by antibody localization, in the apical membrane of PCT and of UB, respectively (21). The pattern of glycosylation from embryonic to postnatal changed in AQP1, similar to that in rat AQP2 (7), such that the nonglycosylated protein was present throughout ontogeny, but the glycosylated subunits of AQP1 were detected only after birth, and AQP-1 in mature PCT and descending thin limb has been localized to the apical and basolateral membrane (21). AQP2, by contrast, is expressed only in UB-derived structures, beginning at gestational week 12 (21). Remarkably, V-ATPase was not detected at any embryonic stage in UB-derived cells (21), which further characterizes the collecting duct progenitor cell as a principal cell-like type (43, 46).

AQP1 mRNA is not expressed in mesonephros (E15-60, sheep); it appears in the metanephric PCT at a low level on E40 (11), and transcript abundance rises some sevenfold in the last trimester of gestation to reach adult levels in week 6 (104). AQP1 mRNA expression, similar to AQP2 in rat (106), increased by 43% on midgestational E74 (but not earlier) after glucocorticoid administration (104).

Lung water channel transcript expression, when analyzed systematically from E19 to P21 in rat (94), reveals distinct patterns for AQP1, 4, and 5 (Fig. 4) whereas AQP3 is not expressed in distal lung (54). AQP1 transcript expression, more than that of AQP4, increased simultaneously with osmotic water permeability immediately after birth in rabbit (13). In embryonic rat lung, by contrast, AQP1 protein is the first to appear (54), probably similar to in sheep lung bud (11), and its level rises severalfold from E20 to P1 (53) or to P5 (94), concomitant with the transition from secretion to absorption of lung liquid (53). AQP1 transcript expression had a sharp rise to its maximal transcript value at P2 (94) or P1 (107), and it rose severalfold after maternal treatment with glucocorticoid not only embryonically but also in P1 and even in adult lung (53). The AQP1 ontogenic expression pattern in embryonic lung, and the AQP2 pattern in kidney, appear to parallel those of ENaC (Fig. 5); however, AQP1 is not expressed in epithelia of large airways and of alveoli. AQP4 mRNA has an expression pattern similar to AQP1 (107), beginning on E20 with a sharp rise by a factor of eight to P1/3 (75), and it declines from there by a factor of two during week 1 to almost the adult level (75). This unstimulated pattern of AQP4 is lung specific, and the protein localizes to postnatal basolateral membranes of all airway cells but not to alveolar membranes. It is very relevant functionally that AQP4 responds to a change in O2 from 3 to 21% (75) in a manner similar to the change in ENaC expression, and maximal coexpression of ENaC subunits and AQP4 occurs on P1 (75). AQP4 mRNA increases by some 50% after beta -adrenergic agonists and glucocorticoids (107). The AQP5 transcript, by contrast, has a slow and steady increase from E20 to P5 (94, 107), its maximum expression is after week 1, and there is no change after glucocorticoid treatment (54).


View larger version (93K):
[in this window]
[in a new window]
 
Fig. 5.   Synopsis of expression patterns of principal AQPs and of alpha -ENaC in kidney and lung. Relative abundance of mRNA expression at different stages of morphogenesis, E and P, is represented by width of horizontal lines; thick vertical line, transition from E to P epithelial cell differentiation; circles, ref. nos.

In sum, developmental physiology of AQPs has been proven to be far more intricate than anticipated from work in other transporter families, because fluid transport functions most likely involve multiple AQPs acting in concert to maintain the delicate fluid balance not only on respiratory and secretory surfaces but also within the intracellular space during developmental transitional states.


    PERSPECTIVES
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

Embryonic temporospatial expression patterns of some plasma membrane transporters have been described comparatively between epithelial organs, and they have been related to morphogenetic stages and evolving organ function. The mere description of embryonic expression patterns at the mRNA and immunoprotein level, however, can only provide a basis on which to evaluate causal relations in morphogenesis, cell polarization, and differentiation. Among the presently most interesting approaches to uncover causal links between regulatory entities are those that measure transporter and transcription factor patterns in defined transitional states (47) and interfere with those gene expressions in lung and kidney (e.g., 48, 62), the major embryonic transporter organs. However, we do not wish to leave the impression that this sole approach will enable us to draw a coherent picture of how embryonic epithelial membrane transporter expression is regulated.


    ACKNOWLEDGEMENTS

Sophia Horster is gratefully acknowledged for graphics work.


    FOOTNOTES

Research in the author's laboratory is financially supported by the Deutsche Forschungsgemeinschaft. This article was written during the grant period Ho 485/16-1/16-2.

Address for reprint requests and other correspondence: M. F. Horster, Universität München, Pettenkoferstr. 12, D-80336 Munich, Germany (E-mail: horster.med{at}qmx.de).

1  Horster, M. Principles of nephron differentiation. Am J Physiol Renal Fluid Electrolyte Physiol 235: F387-F394, 1978.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
AMILORIDE-SENSITIVE EPITHELIAL...
INWARDLY RECTIFYING K+ CHANNELS
CHLORIDE TRANSPORTERS
SODIUM-GLUCOSE SYMPORTER-...
NHE
NAPI
ATPASES
AQP
PERSPECTIVES
REFERENCES

1.   Barker, PM, Nguyen MS, Gatzy JT, Grubb B, Norman H, Hummler E, Rossier B, Boucher RC, and Koller B. Role of gamma ENaC subunit in lung liquid clearance and electrolyte balance in newborn mice. Insights into perinatal adaptation and pseudohypoaldosteronism. J Clin Invest 102: 1634-1640, 1998[Abstract/Free Full Text].

2.   Baum, M, Biemesderfer D, Gentry D, and Aronson PS. Ontogeny of rabbit renal cortical NHE3 and NHE1: effect of glucocorticoids. Am J Physiol Renal Fluid Electrolyte Physiol 268: F815-F820, 1995[Abstract/Free Full Text].

3.   Baum, M, Dwarakanath V, Alpern RJ, and Moe OW. Effects of thyroid hormone on the neonatal renal cortical Na+/H+ antiporter. Kidney Int 53: 1254-1258, 1998[ISI][Medline].

4.   Beck, JC, Lipkowitz MS, and Abramson RG. Characterization of the fetal glucose transporter in rabbit kidney. Comparison with the adult brush border electrogenic Na+-glucose transporter. J Clin Invest 82: 379-387, 1988[ISI][Medline].

5.   Beck, JC, Lipkowitz MS, and Abramson RG. Ontogeny of Na/H antiporter activity in rabbit renal brush border membrane vesicles. J Clin Invest 87: 2067-2076, 1991[ISI][Medline].

6.   Biemesderfer, D, Rutherford PA, Nagy T, Pizzonia JH, Abu-Alfa AK, and Aronson PS. Monoclonal antibodies for high-resolution localization of NHE3 in adult and neonatal rat kidney. Am J Physiol Renal Physiol 273: F289-F299, 1997[Abstract/Free Full Text].

7.   Bonilla-Felix, M, and Jiang W. Aquaporin-2 in the immature rat: expression, regulation, and trafficking. J Am Soc Nephrol 8: 1502-1509, 1997[Abstract].

9.   Buddington, RK, and Diamond J. Ontogenetic development of nutrient transporters in cat intestine. Am J Physiol Gastrointest Liver Physiol 263: G605-G616, 1992[Abstract/Free Full Text].

10.   Burrow, CR, Devuyst O, Li X, Gatti L, and Wilson PD. Expression of the beta 2-subunit and apical localization of Na+-K+-ATPase in metanephric kidney. Am J Physiol Renal Physiol 277: F391-F403, 1999[Abstract/Free Full Text].

11.   Butkus, A, Alcorn D, Earnest L, Moritz K, Giles M, and Wintour EM. Expression of aquaporin-1 (AQP1) in the adult and developing sheep kidney. Biol Cell 89: 313-320, 1997[Medline].

12.   Canessa, C, Schild I, Buell G, Thorens B, Gautschi I, Horisberger JD, and Rossier BC. Amiloride-sensitive epithelial sodium channel is made of three homologous subunits. Nature 367: 463-467, 1994[ISI][Medline].

13.   Carter, EP, Umenishi F, Matthay MA, and Verkman AS. Developmental changes in water permeability across the alveolar barrier in perinatal rabbit lung. J Clin Invest 100: 1071-1078, 1997[Abstract/Free Full Text].

14.   Castello, A, Guma A, Sevilla L, Furriols M, Testar X, Palacin M, and Zorzano A. Regulation of GLUT5 gene expression in rat intestinal mucosa: regional distribution, circadian rhythm, perinatal development and effect of diabetes. Biochem J 309: 271-277, 1995[ISI][Medline].

15.   Chapman, DL, Widdicombe JH, and Bland RD. Developmental differences in rabbit lung epithelial cell Na+-K+-ATPase. Am J Physiol Lung Cell Mol Physiol 259: L481-L487, 1990[Abstract/Free Full Text].

16.   Collins, JF, Xu H, Kiela PR, Zeng J, and Ghishan FK. Functional and molecular characterization of NHE3 expression during ontogeny in rat jejunal epithelium. Am J Physiol Cell Physiol 273: C1937-C1946, 1997[Abstract/Free Full Text].

17.   Collins, JF, Xu H, Kiela PR, Zeng J, and Ghishan FK. Ontogeny of basolateral membrane sodium-hydrogen exchange (NHE) activity and mRNA expression of NHE-1 and NHE-4 in rat kidney and jejunum. Biochim Biophys Acta 1369: 247-258, 1998[ISI][Medline].

18.   Constantinescu, A, Silver RB, and Satlin LM. H-K-ATPase activity in PNA-binding intercalated cells of newborn rabbit cortical collecting duct. Am J Physiol Renal Physiol 272: F167-F177, 1997[Abstract/Free Full Text].

19.   Crump, RG, Askew GR, Wert SE, Lingrel JB, and Joiner CH. In situ localization of sodium-potassium ATPase mRNA in developing mouse lung epithelium. Am J Physiol Lung Cell Mol Physiol 269: L299-L308, 1995[Abstract/Free Full Text].

20.   Davidson, NO, Hausman AM, Ifkovits CA, Buse JB, Gould GW, Burant CF, and Bell GI. Human intestinal glucose transporter expression and localization of GLUT-5. Am J Physiol Cell Physiol 262: C795-C800, 1992[Abstract/Free Full Text].

21.   Devuyst, O, Burrow CR, Smith BL, Agre P, Knepper MA, and Wilson PD. Expression of aquaporins-1 and -2 during nephrogenesis and in autosomal dominant polycystic kidney disease. Am J Physiol Renal Fluid Electrolyte Physiol 271: F169-F183, 1996[Abstract/Free Full Text].

22.   Devuyst, O, Burrow CR, Schwiebert EM, Guggino WB, and Wilson PD. Developmental regulation of CFTR expression during human nephrogenesis. Am J Physiol Renal Fluid Electrolyte Physiol 271: F723-F735, 1996[Abstract/Free Full Text].

23.   Euzet, S, Lelievre-Pegorier M, and Merlet-Benichou C. Effect of 3,5,3'-tri-iodothyronine on maturation of rat renal phosphate transport: kinetic characteristics and phosphate transporter messenger ribonucleic acid and protein abundance. Endocrinology 137: 3522-3530, 1996[Abstract].

24.   Finley, N, Norlin A, Baines DL, and Folkesson HG. Alveolar epithelial fluid clearance is mediated by endogenous catecholamines at birth in guinea pigs. J Clin Invest 101: 972-981, 1998[Abstract/Free Full Text].

25.   Furriols, M, Chillaron J, Mora C, Castello A, Bertran J, Camps M, Testar X, Vilaro S, Zorzano A, and Palacin M. rBAT, related to L-cystine transport, is localized to the microvilli of proximal straight tubules, and its expression is regulated in kidney by development. J Biol Chem 268: 27060-27068, 1993[Abstract/Free Full Text].

26.   Garty, H, and Palmer LG. Epithelial sodium channels: function, structure, and regulation. Physiol Rev 77: 359-396, 1997[Abstract/Free Full Text].

27.   Gattone, VH, 2nd, Maser RL, Tian C, Rosenberg JM, and Branden MG. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev Genet 24: 309-318, 1999[ISI][Medline].

28.   Geng, L, Segal Y, Pavlova A, Barros EJ, Lohning C, Lu W, Nigam SK, Frischauf AM, Reeders ST, and Zhou J. Distribution and developmentally regulated expression of murine polycystin. Am J Physiol Renal Physiol 272: F451-F459, 1997[Abstract/Free Full Text].

29.   Geng, L, Segal Y, Peissel B, Deng N, Pei Y, Carone F, Renke HG, Glücksmann-Kuis AM, Schneider MC, Ericsson M, Reeders ST, and Zhou J. Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 98: 2674-2682, 1996[Abstract/Free Full Text].

30.   Giebisch, G. Renal potassium transport: mechanisms and regulation. Am J Physiol Renal Physiol 274: F817-F833, 1998[Abstract/Free Full Text].

31.   Griffin, MD, O'Sullivan DA, Torres VE, Grande JP, Kanwar YS, and Kumar R. Expression of polycystin in mouse metanephros and extrametanephric tissues. Kidney Int 52: 1196-1205, 1997[ISI][Medline].

32.   Guillery, EN, Huss DJ, McDonough AA, and Klein LC. Posttranscriptional upregulation of Na+-K+-ATPase in newborn guinea pig renal cortex. Am J Physiol Renal Physiol 273: F254-F263, 1997[Abstract/Free Full Text].

33.   Guillery, EN, Karniski LP, Mathews MS, Page WV, Orlowski J, Jose PA, and Robillard JE. Role of glucocorticoids in the maturation of renal cortical Na+/H+ exchanger activity during fetal life in sheep. Am J Physiol Renal Fluid Electrolyte Physiol 268: F710-F717, 1995[Abstract/Free Full Text].

34.   Harris, A, Chalkley G, Goodman S, and Coleman L. Expression of the cystic fibrosis gene in human development. Development 113: 305-310, 1991[Abstract].

35.   Hart, CD, Flozak AS, and Simmons RA. Modulation of glucose transport in fetal lung: a sexual dimorphism. Am J Respir Cell Mol Biol 19: 63-70, 1998[Abstract/Free Full Text].

36.   Hathout, EH, Kumagai AK, Sangkharat A, Geffner ME, and Mullen Y. Absence of GLUT2 protein in near-term fetal rat pancreatic islands. Pancreas 14: 318-321, 1997[ISI][Medline].

37.   Hebert, SC. General principles of the structure of ion channels. Am J Med 104: 87-98, 1998[ISI][Medline].

38.   Hogan, BL. Morphogenesis. Cell 96: 225-233, 1999[ISI][Medline].

39.   Horster, M, Huber S, Tschop J, Dittrich G, and Braun G. Epithelial nephrogenesis. Pflügers Arch 434: 647-660, 1997[ISI][Medline].

40.   Horster, MF, Braun GS, and Huber SM. Embryonic renal epithelia: induction, nephrogenesis and cell differentiation. Physiol Rev 79: 1157-1191, 1999[Abstract/Free Full Text].

41.   Huber, S, Braun G, Burger-Kentischer A, Lukow B, and Horster M. CFTR mRNA and its truncated splice variant (TRN-CFTR) are differentially expressed during collecting duct ontogeny. FEBS Lett 423: 362-366, 1998[ISI][Medline].

42.   Huber, S, Braun G, Schroppel B, and Horster M. Chloride channels. ClC-2 and ICln mRNA expression differs in renal epithelial ontogeny. Kidney Int 54: S-149-S-151, 1998.

43.   Huber, S, Schroppel B, Kretzler M, Schlondorff D, and Horster M. Single cell RT-PCR analysis of ClC-2 mRNA expression in ureteric bud tip. Am J Physiol Renal Physiol 274: F951-F957, 1998[Abstract/Free Full Text].

44.   Huber, SM, Braun GS, and Horster MF. Expression of the epithelial sodium channel (ENaC) during ontogenic differentiation of the renal cortical collecting duct epithelium. Pflügers Arch 437: 491-497, 1999[ISI][Medline].

45.   Huber, SM, Braun GS, Segerer S, Veh RW, and Horster MF. Metanephrogenic mesenchyme-to-epithelium transition induces profound expression changes of ion channels. Am J Physiol Renal Physiol 279: F65-F76, 2000[Abstract/Free Full Text].

46.   Huber, SM, and Horster MF. Ontogeny of apical membrane ion conductances and channel expression in cortical collecting duct cells. Am J Physiol Renal Fluid Electrolyte Physiol 271: F698-F708, 1996[Abstract/Free Full Text].

47.   Huber, SM, and Horster MF. Expression of a hypotonic swelling-activated Cl conductance during ontogeny of collecting duct epithelium. Am J Physiol Renal Physiol 275: F25-F32, 1998[Abstract/Free Full Text].

48.   Hummler, E, Barker P, Gatzy J, Beermann F, Verdumo C, Schmidt A, Boucher R, and Rossier BC. Early death due to defective neonatal lung liquid clearance in alpha ENaC-deficient mice. Nature Genet 12: 325-328, 1996[ISI][Medline].

49.   Hummler, E, Barker P, Talbot C, Wang Q, Verdumo C, Grubb B, Gatzy J, Burnier M, Horisberger JD, Beermann F, Boucher R, and Rossier BC. A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism. Proc Natl Acad Sci USA 94: 11710-11715, 1997[Abstract/Free Full Text].

50.   Ibraghimow-Beskrovnaya, O, Dackowski WR, Foggensteiner L, Coleman N, Thiru S, Petry LR, Burn TC, Connors TD, van Raay T, Bradley J, Qian F, Onuchic LF, Watnik TJ, Piontek K, Hakim RM, Landes GM, Germino GG, Sandford R, and Klinger KW. Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci USA 94: 6397-6402, 1997[Abstract/Free Full Text].

51.   Igarashi, P, vanden Heuvel GB, Payne JA, and Forbush B, III. Cloning, embryonic expression, and alternative splicing of a murine kidney-specific Na-K-Cl cotransporter. Am J Physiol Renal Fluid Electrolyte Physiol 269: F405-F418, 1995[Abstract/Free Full Text].

52.   Ingbar, DH, Duvick S, Savick SK, Schellhase DE, Detterding R, Jamieson JD, and Shannon JM. Developmental changes of fetal rat lung Na-K-ATPase after maternal treatment with dexamethasone. Am J Physiol Lung Cell Mol Physiol 272: L665-L672, 1997[Abstract/Free Full Text].

53.   King, LS, Nielsen S, and Agre P. Aquaporin-1 water channel protein in lung. Ontogeny, steroid-induced expression, and distribution in rat. J Clin Invest 97: 2183-2191, 1996[Abstract/Free Full Text].

54.   King, LS, Nielsen S, and Agre P. Aquaporins in complex tissues. I. Developmental patterns in respiratory and glandular tissues of rat. Am J Physiol Cell Physiol 273: C1541-C1548, 1997[ISI][Medline].

55.   Lopez-Nieto, CE, You G, Bush KT, Barros EJG, Beier DR, and Nigam SK. Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem 272: 6471-6478, 1997[Abstract/Free Full Text].

56.   Mahraoui, L, Rousset M, Dussaulx E, Darmoul D, Zweibaum A, and Brot-Laroche E. Expression and localization of GLUT-5 in Caco-2 cells, human small intestine, and colon. Am J Physiol Gastrointest Liver Physiol 263: G312-G318, 1992[Abstract/Free Full Text].

57.   Matsumoto, K, Takao Y, Akazawa S, Yano M, Uotani S, Kawasaki E, Takino H, Yamasaki H, Okuno S, Yamaguchi Y, and Nagataki S. Developmental change of facilitative glucose transporter expression in rat embryonal and fetal intestine. Biochem Biophys Res Commun 193: 1275-1282, 1993[ISI][Medline].

58.   Matsumoto, T, Winkler CA, Brion LP, and Schwartz GJ. Expression of acid-base-related proteins in mesonephric kidney of the rabbit. Am J Physiol Renal Fluid Electrolyte Physiol 267: F987-F997, 1994[Abstract/Free Full Text].

59.   McCray, PB, Jr, Reenstra WW, Louie E, Johnson J, Bettencourt JD, and Bastacky J. Expression of CFTR and presence of cAMP-mediated fluid secretion in human fetal lung. Am J Physiol Lung Cell Mol Physiol 262: L472-L481, 1992[Abstract/Free Full Text].

60.   McCray, PB, Jr, Wohlford-Lenane CL, and Snyder JM. Localization of cystic fibrosis transmembrane conductance regulator mRNA in human fetal lung tissue by in situ hybridization. J Clin Invest 90: 619-625, 1992[ISI][Medline].

61.   McDonald, FJ, Snyder PM, McCray PB, Jr, and Welsh MJ. Cloning, expression, and tissue distribution of a human amiloride-sensitive Na+ channel. Am J Physiol Lung Cell Mol Physiol 266: L728-L734, 1994[Abstract/Free Full Text].

62.   McDonald, FJ, Yang B, Hrstka RF, Drummond HA, Tarr DE, McCray PB, Jr, Stokes JB, Welsh MJ, and Williamson RA. Disruption of the beta  subunit of the epithelial Na+ channel in mice: Hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad Sci USA 96: 1727-1731, 1999[Abstract/Free Full Text].

63.   McGrath, SA, Basu A, and Zeitlin PL. Cystic fibrosis gene and protein expression during fetal lung development. Am J Respir Cell Mol Biol 8: 201-208, 1993[ISI][Medline].

64.   Morley, GP, Callaghan JM, Rose JB, Toh BH, Gleeson PA, and van Driel IR. The mouse gastric H,K-ATPase subunit. Gene structure and co-ordinate expression with the alpha  subunit during ontogeny. J Biol Chem 267: 1165-1174, 1992[Abstract/Free Full Text].

65.   Murray, CB, Chu S, and Zeitlin PL. Gestational and tissue-specific regulation of ClC-2 chloride channel expression. Am J Physiol Lung Cell Mol Physiol 271: L829-L837, 1996[Abstract/Free Full Text].

66.   O'Brodovich, H, Staub O, Rossier BC, Geering K, and Kraehenbuhl JP. Ontogeny of alpha 1- and beta 1-isoforms of Na+-K+-ATPase in fetal distal rat lung epithelium. Am J Physiol Cell Physiol 264: C1137-C1143, 1993[Abstract/Free Full Text].

67.   O'Brodovich, H, Canessa C, Ueda J, Rafii B, Rossier BC, and Edelson J. Expression of the epithelial Na+ channel in the developing rat lung. Am J Physiol Cell Physiol 265: C491-C496, 1993[Abstract/Free Full Text].

68.   Ostrowski, NL, Young WS, III., Knepper MA, and Lolait SL. Expression of vasopressin V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, and adult rats. Endocrinology 133: 1849-1859, 1993[Abstract].

69.   Pang, K, Mukonoweshuro C, and Wong GG. Beta cells arise from glucose transporter type 2 (Glut2)-expressing epithelial cells of developing rat pancreas. Proc Natl Acad Sci USA 91: 9559-9563, 1994[Abstract/Free Full Text].

70.   Petershack, JA, Nagaraja SC, and Guillery EN. Role of glucocorticoids in the maturation of renal cortical Na+-K+-ATPase during fetal life in sheep. Am J Physiol Regulatory Integrative Comp Physiol 276: R1825-R1832, 1999[Abstract/Free Full Text].

71.   Pitkänen, O, Tanswell AK, Downey G, and O'Brodovich H. Increased PO2 alters the bioelectric properties of fetal distal lung epithelium. Am J Physiol Lung Cell Mol Physiol 270: L1060-L1066, 1996[Abstract/Free Full Text].

72.   Pradervand, S, Barker PM, Q, Wang Ernst SA, Beermann F, Grubb BR, Burnier M, Schmidt A, Bindels RJM, Gatzy JT, Rossier BC, and Hummler E. Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta -subunit of the amiloride-sensitive epithelial sodium channel. Proc Natl Acad Sci USA 96: 1732-1737, 1999[Abstract/Free Full Text].

73.   Puchal, AA, and Buddington RK. Postnatal development of monosaccharide transport in pig intestine. Am J Physiol Gastrointest Liver Physiol 262: G895-G902, 1992[Abstract/Free Full Text].

74.   Rafii, B, Tanswell AK, Otulakowski G, Pitkänen O, Belcastro-Taylor R, and O'Brodovich H. O2-induced ENaC expression is associated with NF-kappa B activation and blocked by superoxide scavenger. Am J Physiol Lung Cell Mol Physiol 275: L764-L770, 1998[Abstract/Free Full Text].

75.   Ruddy, MK, Drazen JM, Pitkänen OM, Rafii B, O'Brodovich HM, and Harris HW. Modulation of aquaporin 4 and the amiloride-inhibitable sodium channel in perinatal rat lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 274: L1066-L1072, 1998[Abstract/Free Full Text].

76.   Sabolic, I, Katsura T, Verbavatz JM, and Brown D. The AQP2 water channel: effect of vasopressin treatment, microtubule disruption, and distribution in neonatal rats. J Membr Biol 143: 165-175, 1995[ISI][Medline].

77.   Satlin, LM, and Palmer LG. Apical K+ conductance in maturing rabbit principal cells. Am J Physiol Renal Physiol 272: F397-F404, 1997[Abstract/Free Full Text].

78.   Schmitt, R, Ellison DH, Farman N, Rossier BC, Reilly RF, Reeves WB, Oberbaumer I, Tapp R, and Bachmann S. Developmental expression of sodium entry pathways in rat nephron. Am J Physiol Renal Physiol 276: F367-F381, 1999[Abstract/Free Full Text].

79.   Schwiebert, EM, Benos DJ, Egan ME, Stutts MJ, and Guggino WB. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 79: S145-S166, 1999[Medline].

80.   Sha, M, Quigley R, and Baum M. Maturation of rabbit proximal straight tubule chloride/base exchange. Am J Physiol Renal Physiol 274: F883-F888, 1998[Abstract/Free Full Text].

81.   Shneider, BL, Setchell KDR, and Crossman MW. Fetal and neonatal expression of the apical sodium-dependent bile acid transporter in the rat ileum and kidney. Pediatr Res 42: 189-194, 1997[Abstract].

82.   Shu, R, David ES, and Ferraris RP. Luminal fructose modulates fructose transport and GLUT-5 expression in small intestine of weaning rats. Am J Physiol Gastrointest Liver Physiol 274: G232-G239, 1998[Abstract/Free Full Text].

83.   Siga, E, and Horster MF. Regulation of osmotic water permeability during differentiation of inner medullary collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 260: F710-F716, 1991[Abstract/Free Full Text].

84.   Simmons, RA, Flozak AS, and Ogata ES. Glucose regulates Glut 1 function and expression in fetal rat lung and muscle in vitro. Endocrinology 132: 2312-2318, 1993[Abstract].

85.   Simon, DB, Karet FE, Hamdan JM, Di Pietro A, Sanjad SA, and Lifton RP. Bartter's syndrome, hypokaliaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nature Genet 13: 183-188, 1996[ISI][Medline].

86.   Sweezey, NB, Ghibu F, and Gagnon S. Sex hormones regulate CFTR in developing fetal rat lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 272: L844-L851, 1997[Abstract/Free Full Text].

87.   Talbot, CL, Bosworth DG, Briley EL, Fenstermacher DA, Boucher RC, Gabriel SE, and Barker PM. Quantitation and localization of ENaC subunit expression in fetal, newborn, and adult mouse lung. Am J Respir Cell Mol Biol 20: 398-406, 1999[Abstract/Free Full Text].

88.   Tchepichev, S, Ueda J, Canessa C, Rossier BC, and O'Brodovich H. Lung epithelial Na channel subunits are differentially regulated during development and by steroids. Am J Physiol Cell Physiol 269: C805-C812, 1995[Abstract].

89.   Tessier, GJ, Lester GD, Langham MR, and Cassin S. Ion transport properties of fetal sheep alveolar epithelial cells in monolayer culture. Am J Physiol Lung Cell Mol Physiol 270: L1008-L1016, 1996[Abstract/Free Full Text].

90.   Tizzano, EF, Chitayat D, and Buchwald M. Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. Hum Mol Genet 2: 219-224, 1993[Abstract].

91.   Tizzano, EF, O'Brodovich H, Chitayat D, Benichou JC, and Buchwald M. Regional expression of CFTR in developing human respiratory tissues. Am J Respir Cell Mol Biol 10: 355-362, 1994[Abstract].

92.   Toloza, EM, and Diamond J. Ontogenetic development of nutrient transporters in rat intestine. Am J Physiol Gastrointest Liver Physiol 263: G593-G604, 1992[Abstract/Free Full Text].

93.   Traebert, M, Lötscher M, Aschwanden R, Ritthaler T, Biber J, Murer H, and Kaissling B. Distribution of the sodium-phosphate transporter (NaPi-2) during the postnatal ontogeny of the rat kidney. J Am Soc Nephrol 10: 1407-1415, 1999[Abstract/Free Full Text].

94.   Umenishi, F, Carter EP, Yang B, Oliver B, Matthay MA, and Verkman AS. Sharp increase in rat lung water channel expression in the perinatal period. Am J Respir Cell Mol Biol 15: 673-679, 1996[Abstract].

95.   Van Adelsberg, J. Peptides from the PKD repeats of polycystin, the PKD1 gene product, modulate pattern formation in the developing kidney. Dev Genet 24: 299-308, 1999[ISI][Medline].

96.   Vargas-Pussou, R, Feldmann D, Vollmer M, Konrad M, Kelly L, van den Heuvel LP, Tebourbi L, Brandis M, Karolyi L, Hebert SC, Lemmink HH, Deschenes G, Hildebrandt F, Seyberth HW, Guay-Woodford LM, Knoers NV, and Antignac C. Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet 62: 1332-1340, 1998[ISI][Medline].

97.   Vehaskari, VM, Hempe JM, Manning J, Aviles DH, and Carmichael MC. Developmental regulation of ENaC subunit mRNA levels in rat kidney. Am J Physiol Cell Physiol 274: C1661-C1666, 1998[Abstract/Free Full Text].

98.   Venkatesh, VC, and Katzberg HD. Glucocorticoid regulation of epithelial sodium channel genes in human fetal lung. Am J Physiol Lung Cell Mol Physiol 273: L227-L233, 1997[Abstract/Free Full Text].

99.   Voilley, N, Lingueglia E, Champigny G, Mattei MG, Waldmann R, Lazdunski M, and Barbry P. The lung amiloride-sensitive Na+ channel: biophysical properties, pharmacology, ontogenesis, and molecular cloning. Proc Natl Acad Sci USA 91: 247-251, 1994[Abstract].

100.   Watanabe, S, Matsushita K, McCray PB, Jr, and Stokes JB. Developmental expression of the epithelial Na+ channel in kidney and uroepithelia. Am J Physiol Renal Physiol 276: F304-F324, 1999[Abstract/Free Full Text].

101.   Watanabe, S, Matsushita K, Stokes JB, and McCray PB, Jr. Developmental regulation of epithelial sodium channel subunit mRNA expression in rat colon and lung. Am J Physiol Gastrointest Liver Physiol 275: G1227-G1235, 1998[Abstract/Free Full Text].

102.   Wickman, K, Seldin MF, James MR, Gendler SJ, and Clapham DE. Partial structure, chromosome localization, and expression of the mouse ICln gene. Genomics 40: 402-408, 1997[ISI][Medline].

103.   Wijkhuisen, A, Djouadi F, Vilar J, Merlet-Benichou C, and Bastin J. Birth-related changes in energy metabolism enzymes and Na-K-ATPase in kidney proximal convoluted tubule cells. Am J Physiol Cell Physiol 272: C787-C793, 1997[Abstract/Free Full Text].

104.   Wintour, EM, Earnest L, Alcorn D, Butkus A, Shandley L, and Jeyaseelan K. Ovine AQP1: cDNA cloning, ontogeny, and control of renal gene expression. Pediatr Nephrol 12: 545-553, 1998[ISI][Medline].

105.   Yamamoto, T, Sasaki S, Fushimi K, Ishibashi K, Yaoita E, Kawasaki K, Fujinaka H, Marumo F, and Kihara I. Expression of AQP family in rat kidneys during development and maturation. Am J Physiol Renal Physiol 272: F198-F204, 1997[Abstract/Free Full Text].

106.   Yasui, M, Marples D, Belusa R, Eklof AC, Celsi G, Nielsen S, and Aperia A. Development of urinary concentrating capacity: role of aquaporin-2. Am J Physiol Renal Fluid Electrolyte Physiol 271: F461-F468, 1996[Abstract/Free Full Text].

107.   Yasui, M, Serlachius E, Lofgren M, Belusa R, Nielsen S, and Aperia A. Perinatal changes in expression of aquaporin-4 and other water and ion transporters in rat lung. J Physiol (Lond) 505: 3-11, 1997[Abstract].

108.   You, G, Lee WS, Barros EJ, Kanai Y, Huo TL, Khawaja S, Wells RG, Nigam SK, and Hediger MA. Molecular characteristics of Na+-coupled glucose transporters in adult and embryonic rat kidney. J Biol Chem 270: 29365-29371, 1995[Abstract/Free Full Text].

109.   Zelikovic, I, Stejskal E, Lohstroh P, Budreau A, and Chesney RW. Developmental maturation of Na+-H+ exchange in rat renal tubular brush-border membrane. Am J Physiol Renal Fluid Electrolyte Physiol 261: F1017-F1025, 1991[Abstract/Free Full Text].

110.   Zhou, L, Graeff RW, McCray PB, Jr, Simonet WS, and Whitsett JA. Keratinocyte growth factor stimulates CFTR-independent fluid secretion in the fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 271: L987-L994, 1996[Abstract/Free Full Text].

111.   Zolotnitskaya, A, and Satlin LM. Developmental expression of ROMK in rat kidney. Am J Physiol Renal Physiol 276: F825-F836, 1999[Abstract/Free Full Text].


Am J Physiol Renal Fluid Electrolyte Physiol 279(6):F982-F996
0363-6127/00 $5.00 Copyright © 2000 the American Physiological Society